---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-023016"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T13:49:59.832337+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# TRxADE Health to acquire Superlatus, shifting to food & snack industry; new shares to be issued.

## Summary
- Superlatus shareholders receive 173,463 MEDS shares (136,436 common, 37,027 Series B preferred convertible at 100:1).
- MEDS to divest its existing operating business and assets shortly after the merger closes.
- Superlatus must acquire Prestige Farms and Sapientia; valuation must be at least $225M.
- Combined company to create global consolidation platform for food and healthy snacks.
- Merger expected to close in late Q3 or early Q4 2023; Boards unanimously approved.

## SEC filing metadata
- accession: 0001493152-23-023016
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/0001493152-23-023016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-023016
- JSON: https://secwatch.observer/filing/0001493152-23-023016.json
- Plain text: https://secwatch.observer/filing/0001493152-23-023016.txt

## Key facts
- Material Agreements
  Scienture Holdings, Inc. entered into Agreement and Plan of Merger with Superlatus Inc. (effective 2023-06-30).
  - Action: entry
  - Agreement: merger
  - Counterparty: Superlatus Inc.
  - Effective: 2023-06-30
  source text: On June 30, 2023, TRxADE Health, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Superlatus Inc., a Delaware corporation (“Superlatus”), and Foods Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/0001493152-23-023016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.